The Biotech Growth Trust PLC (BIOG) — Cash Flow Quality Index
The Biotech Growth Trust PLC (BIOG) has a Cash Flow Quality Index of -0.04x as of September 2025. Operating cash flow of GBX-2.52 Million is below net income of GBX69.42 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore The Biotech Growth Trust PLC (BIOG) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
The Biotech Growth Trust PLC Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for The Biotech Growth Trust PLC across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check The Biotech Growth Trust PLC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for The Biotech Growth Trust PLC (2012–2024)
Year-by-year earnings quality comparison for The Biotech Growth Trust PLC. For live market cap and the full company financial profile, see The Biotech Growth Trust PLC (BIOG) total market value.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | GBX-4.24 Million | GBX74.60 Million | ▼ -100.9% |
| 2021 | -0.03x | GBX-5.67 Million | GBX200.56 Million | ▲ +54.1% |
| 2020 | -0.06x | GBX-3.77 Million | GBX61.09 Million | ▲ +70.2% |
| 2019 | -0.21x | GBX-4.40 Million | GBX21.29 Million | ▼ -285.5% |
| 2017 | -0.05x | GBX-5.29 Million | GBX98.58 Million | ▼ -1735.0% |
| 2015 | 0.00x | GBX703.00K | GBX214.39 Million | ▲ +100.5% |
| 2014 | -0.60x | GBX-52.25 Million | GBX86.43 Million | ▼ -4091.8% |
| 2013 | 0.02x | GBX1.15 Million | GBX76.21 Million | ▲ +239.9% |
| 2012 | -0.01x | GBX-439.00K | GBX40.55 Million | — |